View Older Stories View More Recent Stories
-
Lazard (LAZ) Tops Q3 EPS by 9c
-
Lazard Class A (LAZ) Declares $0.25 Quarterly Dividend; 2.7% Yield
-
Trading Radar for 10/24: Microsoft (MSFT), Hershey (HSY), Western DIgital (WDC), Potash Corp (POT), Under Armour (UA) Report
-
Apple (AAPL) iPad Event Reaffirms Focus on Storage - Analyst
-
Vanda Pharma (VNDA) Defended at Lazard Capital
-
'Mass Exodus' at Lazard Capital Markets - FBN
-
Savient Pharma (SVNT) 'First-Dat' Motions Approved by U.S. Bankruptcy Court
-
Notable Mergers and Acquisitions of the Day 10/15: (AZN) (TUC) (VMW) (YNDX)
-
aerie pharmaceuticals (AERI) Sees IPO Price of $12 - $14/Share
-
Savient Pharma (SVNT) Files for Chapter 11 Bankruptcy
-
AstraZeneca (AZN) to Acquire Spirogen in Up to $440M Deal
-
Aratana Therapeutics (PETX) to Acquire Vet Therapeutics in Cash, Stock Deal
-
VIVUS (VVUS) Investor Calls Lazard Capital Markets Report 'Fundamentally Flawed'
-
MacroGenics (MGNX) IPO Surges 50%
-
MacroGenics (MGNX) IPO Prices at $16, In-Line with Expectations
-
Notable 52-Week Highs and Lows of the Day 10/07: (MU) (CTIC) (GWPH) High; (ATOS) (JCP) (ACFN) Low
-
Unusual 11 Mid-Day Movers 10/07: (VISN) (GWPH) (ALTI) Higher; (ATOS) (ACFN) (EVK) Lower
-
Pre-Open Stock Movers 10/7: (OUTR) (BBRY) (LAZ) Higher; (ATOS) (DRYS) (PWRD) Lower (more...)
-
GW Pharma (GWPH) Target Raised to $65 at Lazard Capital
-
Goldman Sachs Upgrades Lazard (LAZ) to Conviction Buy
-
Barracuda Networks (CUDA) Files $100M IPO
-
Lazard (LAZ) Capital Markets Says No Deal Announcement Imminent
-
Speculation of Imminent Lazard (LAZ) Sale, MBO, or Shutdown - FBN's Gasparino
-
Lazard Keeps Western Digital (WDC) at Buy Following Departure of CFO Nickl
-
TherapeuticsMD (TXMD) Prices 13.75M Offering at $2.40/Share
-
Novavax (NVAX) Prices 27.7M Common Offering at $3.14/Share
-
Streetinsider.com's Hot Lunchtime Reads 09/23: (TSLA) (AAPL) (MCP) (GMCR)
-
Lazard Maintains Buy on Apple (AAPL); iPhone, iOS 7 Numbers Make Street Ests Seem 'Light'
-
Streetinsider.com's Hot Lunchtime Reads 09/20: (FEYE) (AAPL) (TTWO) (NOK)
-
Lazard Keeps Emulex (ELX) at Buy; Stagnant Core Markets Causing Shift in Focus
-
Pre-Open Stock Movers 9/19: (ACUR) (RAD) (A) Higher; (PIR) (ROYT) (SCS) Lower (more...)
-
After-Hours Stock Movers 9/18: (TSPT) (TSLA) Higher; (SCS) (ORCL) (SSH) Lower (more...)
-
Sunshine Heart (SSH) to Offer Common Shares
-
Pre-Open Stock Movers 9/18: (ATOS) (AFOP) (ADBE) Higher; (SGMO) (FIVE) (FLTX) Lower (more...)
-
Sangamo Bio (SGMO) Prices 6.1M Offering at $10.58/Share
-
Lazard Keeps Teradata (TDC) at Buy Following Management Meeting; Likes Long-Term Outlook
-
After-Hours Stock Movers 9/17: (AFOP) (ADBE) (DLTR) Higher; (SGMO) (FIVE) Lower (more...)
-
aerie pharmaceuticals (AERI) Files $57.5M IPO
-
Sangamo Bio (SGMO) Plans to Offer Common Stock
-
Lazard Capital Downgrades Cavium Networks (CAVM) to Neutral
-
The U.K. Plans to Sell 6% of Lloyds Banking Group (LYG)
-
Notable M&A of the Day 09/16: (PKG)/(BZ) (KMT)/(ATI) (POST) (CRTX) (CMLS)
-
Cornerstone Therapeutics (CRTX) Acquired by Chiesi for $9.50/Share
-
Lazard Capital Downgrades MedAssets (MDAS) to Neutral
-
UPDATE: Qualcomm (QCOM) Remains Neutral at Lazard
-
Wall Street Jeers Apple's (AAPL) iPhone 5C Pricing
-
Lazard Capital Starts Sophiris Bio (SPHS) at Buy
-
Lazard Boosts PT on Apple (AAPL) to $570; iPhone 5C Still Boasts Juicy NAND Margins
-
Cisco's (CSCO) Whiptail Acquisition Hints at Stronger Move Into Storage - Analyst
-
Lazard Keeps Fusion-io (FIO) at Buy; Western Digital Pays Premium for Virident

